{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Yang Y"],"funding":["NIA NIH HHS","NCI NIH HHS"],"pagination":["49-60"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8950161"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["3(1)"],"pubmed_abstract":["Aim
Diabetic nephropathy (DN) has become the most common cause of end-stage renal disease (ESRD) in most countries. Elucidating novel epigenetic contributors to DN can not only enhance our understanding of this complex disorder, but also lay the foundation for developing more effective monitoring tools and preventive interventions in the future, thus contributing to our ultimate goal of improving patient care.Methods
The 5hmC-Seal, a highly selective, chemical labeling technique, was used to profile genome-wide 5-hydroxymethylcytosines (5hmC), a stable cytosine modification type marking gene activation, in circulating cell-free DNA (cfDNA) samples from a cohort of patients recruited at Zhongnan Hospital, including T2D patients with nephropathy (DN, n = 12), T2D patients wit"],"journal":["Extracellular vesicles and circulating nucleic acids"],"pubmed_title":["Genome-wide Analysis Reflects Novel 5-Hydroxymethylcytosines Implicated in Diabetic Nephropathy and the Biomarker Potential."],"pmcid":["PMC8950161"],"funding_grant_id":["R21 CA187869","RF1 AG074549"],"pubmed_authors":["Zhang W","Zeng C","Cai Q","He C","Yang Y","Yang K","Zhang Z","Xu S","Liu SM"],"additional_accession":[]},"is_claimable":false,"name":"Genome-wide Analysis Reflects Novel 5-Hydroxymethylcytosines Implicated in Diabetic Nephropathy and the Biomarker Potential.","description":"Aim
Diabetic nephropathy (DN) has become the most common cause of end-stage renal disease (ESRD) in most countries. Elucidating novel epigenetic contributors to DN can not only enhance our understanding of this complex disorder, but also lay the foundation for developing more effective monitoring tools and preventive interventions in the future, thus contributing to our ultimate goal of improving patient care.Methods
The 5hmC-Seal, a highly selective, chemical labeling technique, was used to profile genome-wide 5-hydroxymethylcytosines (5hmC), a stable cytosine modification type marking gene activation, in circulating cell-free DNA (cfDNA) samples from a cohort of patients recruited at Zhongnan Hospital, including T2D patients with nephropathy (DN, n = 12), T2D patients wit","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022","modification":"2026-03-17T16:07:43.617Z","creation":"2025-04-07T08:19:02.787Z"},"accession":"S-EPMC8950161","cross_references":{"pubmed":["35342902"],"doi":["10.20517/evcna.2022.03"]}}